Prophase Labs Stock Technical Analysis
| PRPH Stock | USD 0.16 0.01 5.88% |
As of the 5th of February, ProPhase Labs holds the Risk Adjusted Performance of (0.24), variance of 138.97, and Coefficient Of Variation of (294.55). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of ProPhase Labs, as well as the relationship between them.
ProPhase Labs Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as ProPhase, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ProPhaseProPhase Labs' Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.ProPhase Labs Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 13.8 | Strong Buy | 1 | Odds |
Most ProPhase analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand ProPhase stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of ProPhase Labs, talking to its executives and customers, or listening to ProPhase conference calls.
Is there potential for Pharmaceuticals market expansion? Will ProPhase introduce new products? Factors like these will boost the valuation of ProPhase Labs. Anticipated expansion of ProPhase directly elevates investor willingness to pay premium valuations. Understanding fair value requires weighing current performance against future potential. All the valuation information about ProPhase Labs listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.95) | Earnings Share (19.80) | Revenue Per Share | Quarterly Revenue Growth (0.38) | Return On Assets |
The market value of ProPhase Labs is measured differently than its book value, which is the value of ProPhase that is recorded on the company's balance sheet. Investors also form their own opinion of ProPhase Labs' value that differs from its market value or its book value, called intrinsic value, which is ProPhase Labs' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because ProPhase Labs' market value can be influenced by many factors that don't directly affect ProPhase Labs' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between ProPhase Labs' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding ProPhase Labs should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, ProPhase Labs' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
ProPhase Labs 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to ProPhase Labs' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of ProPhase Labs.
| 11/07/2025 |
| 02/05/2026 |
If you would invest 0.00 in ProPhase Labs on November 7, 2025 and sell it all today you would earn a total of 0.00 from holding ProPhase Labs or generate 0.0% return on investment in ProPhase Labs over 90 days. ProPhase Labs is related to or competes with Cencora, Regeneron Pharmaceuticals, IDEXX Laboratories, Haleon Plc, Cigna Corp, Elevance Health, and Becton Dickinson. ProPhase Labs, Inc. engages in the research, development, manufacture, distribution, marketing, and sale of over the cou... More
ProPhase Labs Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure ProPhase Labs' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess ProPhase Labs upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.34) | |||
| Maximum Drawdown | 77.27 | |||
| Value At Risk | (22.22) | |||
| Potential Upside | 11.11 |
ProPhase Labs Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for ProPhase Labs' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as ProPhase Labs' standard deviation. In reality, there are many statistical measures that can use ProPhase Labs historical prices to predict the future ProPhase Labs' volatility.| Risk Adjusted Performance | (0.24) | |||
| Jensen Alpha | (3.84) | |||
| Total Risk Alpha | (4.89) | |||
| Treynor Ratio | 1.25 |
ProPhase Labs February 5, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.24) | |||
| Market Risk Adjusted Performance | 1.26 | |||
| Mean Deviation | 7.91 | |||
| Coefficient Of Variation | (294.55) | |||
| Standard Deviation | 11.79 | |||
| Variance | 138.97 | |||
| Information Ratio | (0.34) | |||
| Jensen Alpha | (3.84) | |||
| Total Risk Alpha | (4.89) | |||
| Treynor Ratio | 1.25 | |||
| Maximum Drawdown | 77.27 | |||
| Value At Risk | (22.22) | |||
| Potential Upside | 11.11 | |||
| Skewness | 1.3 | |||
| Kurtosis | 6.21 |
ProPhase Labs Backtested Returns
ProPhase Labs maintains Sharpe Ratio (i.e., Efficiency) of -0.32, which implies the firm had a -0.32 % return per unit of risk over the last 3 months. ProPhase Labs exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check ProPhase Labs' Coefficient Of Variation of (294.55), variance of 138.97, and Risk Adjusted Performance of (0.24) to confirm the risk estimate we provide. The company holds a Beta of -3.22, which implies a somewhat significant risk relative to the market. As returns on the market increase, returns on owning ProPhase Labs are expected to decrease by larger amounts. On the other hand, during market turmoil, ProPhase Labs is expected to outperform it. At this point, ProPhase Labs has a negative expected return of -3.95%. Please make sure to check ProPhase Labs' treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if ProPhase Labs performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.81 |
Very good predictability
ProPhase Labs has very good predictability. Overlapping area represents the amount of predictability between ProPhase Labs time series from 7th of November 2025 to 22nd of December 2025 and 22nd of December 2025 to 5th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of ProPhase Labs price movement. The serial correlation of 0.81 indicates that around 81.0% of current ProPhase Labs price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.81 | |
| Spearman Rank Test | 0.73 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
ProPhase Labs technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
ProPhase Labs Technical Analysis
The output start index for this execution was fifty with a total number of output elements of eleven. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of ProPhase Labs volatility. High ATR values indicate high volatility, and low values indicate low volatility.
About ProPhase Labs Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of ProPhase Labs on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of ProPhase Labs based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on ProPhase Labs price pattern first instead of the macroeconomic environment surrounding ProPhase Labs. By analyzing ProPhase Labs's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of ProPhase Labs's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to ProPhase Labs specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 294.52 | 1.1K | 973.27 | 1.0K | PTB Ratio | 0.79 | 1.96 | 2.26 | 2.15 |
ProPhase Labs February 5, 2026 Technical Indicators
Most technical analysis of ProPhase help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for ProPhase from various momentum indicators to cycle indicators. When you analyze ProPhase charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.24) | |||
| Market Risk Adjusted Performance | 1.26 | |||
| Mean Deviation | 7.91 | |||
| Coefficient Of Variation | (294.55) | |||
| Standard Deviation | 11.79 | |||
| Variance | 138.97 | |||
| Information Ratio | (0.34) | |||
| Jensen Alpha | (3.84) | |||
| Total Risk Alpha | (4.89) | |||
| Treynor Ratio | 1.25 | |||
| Maximum Drawdown | 77.27 | |||
| Value At Risk | (22.22) | |||
| Potential Upside | 11.11 | |||
| Skewness | 1.3 | |||
| Kurtosis | 6.21 |
ProPhase Labs February 5, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as ProPhase stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.06 | ||
| Daily Balance Of Power | (1.00) | ||
| Rate Of Daily Change | 0.94 | ||
| Day Median Price | 0.17 | ||
| Day Typical Price | 0.16 | ||
| Price Action Indicator | (0.01) | ||
| Market Facilitation Index | 0.01 |
Complementary Tools for ProPhase Stock analysis
When running ProPhase Labs' price analysis, check to measure ProPhase Labs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ProPhase Labs is operating at the current time. Most of ProPhase Labs' value examination focuses on studying past and present price action to predict the probability of ProPhase Labs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ProPhase Labs' price. Additionally, you may evaluate how the addition of ProPhase Labs to your portfolios can decrease your overall portfolio volatility.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. |